Literature DB >> 8606564

Prenatal diagnosis of Batten's disease.

P B Munroe1, J Rapola, H M Mitchison, A Mustonen, S E Mole, R M Gardiner, I Jarvela.   

Abstract

BACKGROUND: Batten's disease is the most common progressive encephalopathy of childhood in Western countries. The major mutation is a 1kb deletion, which is carried by 81% of Batten's disease patients. We report on the use of direct gene analysis in the prenatal diagnosis of this disease. METHODS AND
FINDINGS: A Finnish woman with a son with Batten's disease came for genetic counselling for her current pregnancy. Electron microscopy of a chorionic villus sample gave suggestive findings. We used PCR to look for the intragenic microsatellite marker D16S298; 96% of Finnish Batten's disease patients carry allele 6 at this marker. The fetus and the affected son both carried the same high-risk genotype, 6/6. Both were homozygous for the 1 kb deletion. The pregnancy was terminated. Electron microscopy of the fetus showed typical Batten's disease changes.
INTERPRETATION: We have successfully used direct gene analysis in the prenatal diagnosis of Batten's disease.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8606564     DOI: 10.1016/s0140-6736(96)90148-8

Source DB:  PubMed          Journal:  Lancet        ISSN: 0140-6736            Impact factor:   79.321


  10 in total

Review 1.  Neuronal ceroid lipofuscinoses: a review.

Authors:  N Nardocci; F Cardona
Journal:  Ital J Neurol Sci       Date:  1998-10

Review 2.  The Finnish Disease Heritage III: the individual diseases.

Authors:  Reijo Norio
Journal:  Hum Genet       Date:  2003-03-08       Impact factor: 4.132

3.  Spectrum of mutations in the Batten disease gene, CLN3.

Authors:  P B Munroe; H M Mitchison; A M O'Rawe; J W Anderson; R M Boustany; T J Lerner; P E Taschner; N de Vos; M H Breuning; R M Gardiner; S E Mole
Journal:  Am J Hum Genet       Date:  1997-08       Impact factor: 11.025

Review 4.  Correlations between genotype, ultrastructural morphology and clinical phenotype in the neuronal ceroid lipofuscinoses.

Authors:  Sara E Mole; Ruth E Williams; Hans H Goebel
Journal:  Neurogenetics       Date:  2005-09-28       Impact factor: 2.660

5.  Rapid diagnostic test for the major mutation underlying Batten disease.

Authors:  I Järvelä; H M Mitchison; P B Munroe; A M O'Rawe; S E Mole; A C Syvänen
Journal:  J Med Genet       Date:  1996-12       Impact factor: 6.318

Review 6.  Retinitis pigmentosa, pigmentary retinopathies, and neurologic diseases.

Authors:  M Tariq Bhatti
Journal:  Curr Neurol Neurosci Rep       Date:  2006-09       Impact factor: 5.081

7.  Rapid detection of the major deletion in the Batten disease gene CLN3 by allele specific PCR.

Authors:  P E Taschner; N de Vos; M H Breuning
Journal:  J Med Genet       Date:  1997-11       Impact factor: 6.318

Review 8.  Recent Insight into the Genetic Basis, Clinical Features, and Diagnostic Methods for Neuronal Ceroid Lipofuscinosis.

Authors:  Konrad Kaminiów; Sylwia Kozak; Justyna Paprocka
Journal:  Int J Mol Sci       Date:  2022-05-20       Impact factor: 6.208

Review 9.  Juvenile neuronal ceroid lipofuscinosis (JNCL) and the eye.

Authors:  Sara Bozorg; Denia Ramirez-Montealegre; Mina Chung; David A Pearce
Journal:  Surv Ophthalmol       Date:  2009 Jul-Aug       Impact factor: 6.048

Review 10.  Therapeutic landscape for Batten disease: current treatments and future prospects.

Authors:  Tyler B Johnson; Jacob T Cain; Katherine A White; Denia Ramirez-Montealegre; David A Pearce; Jill M Weimer
Journal:  Nat Rev Neurol       Date:  2019-03       Impact factor: 42.937

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.